Literature DB >> 9105209

Evaluation and treatment of gynecomastia.

J F Neuman1.   

Abstract

Gynecomastia is a proliferation of the glandular component of the male breast. Causes include altered estrogen-androgen levels, aging, puberty, chronic disease, tumors and drugs. The physician must determine whether the condition has a physiologic or pathologic cause. Pubertal gynecomastia is generally physiologic and regresses without treatment. The likelihood of pathology is increased in patients over 26 years of age who present with new-onset gynecomastia. A thorough history, a complete physical examination and an appropriate clinical evaluation facilitate the prompt diagnosis and treatment of this condition.

Entities:  

Mesh:

Year:  1997        PMID: 9105209

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  4 in total

1.  NAC Plaster Lifting Technique for the Management of Skin Redundancy in Severe Gynecomastia.

Authors:  Karthik Ramasamy; Appaka C V Jagadish Kiran; Joyce Jesudass; Sunitha Raj
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-05-19

2.  The Satisfaction Rate among Patients and Surgeons after Periareolar Surgical Approach to Gynecomastia along with Liposuction.

Authors:  Ahmad Reza Taheri; Mohamad Reza Farahvash; Hamid Reza Fathi; Koorosh Ghanbarzadeh; Bijan Faridniya
Journal:  World J Plast Surg       Date:  2016-09

3.  Gynecomastia in German soldiers: etiology and pathology.

Authors:  Hans-Peter Kuhne; Sandy Egler; Stefan Lenz; André Lieber; Dietrich Doll; Björn Dirk Krapohl
Journal:  GMS Interdiscip Plast Reconstr Surg DGPW       Date:  2012-01-09

4.  Clinical and Etiological Aspects of Gynecomastia in Adult Males: A Multicenter Study.

Authors:  Pablo René Costanzo; Néstor Antonio Pacenza; Sergio Mario Aszpis; Sebastián Matías Suárez; Uriel Marcelo Pragier; Jorge Guillermo Stewart Usher; Miguel Vásquez Cayoja; Sergio Iturrieta; Silvia Elisa Gottlieb; Rodolfo Alberto Rey; Pablo Knoblovits
Journal:  Biomed Res Int       Date:  2018-05-29       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.